Dose model for stent-based delivery of a radioactive compound for the treatment of restenosis in coronary arteries
- 17 September 2003
- journal article
- Published by Wiley in Medical Physics
- Vol. 30 (10) , 2622-2628
- https://doi.org/10.1118/1.1607506
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Drug-eluting stents in vascular interventionThe Lancet, 2003
- Intravascular brachytherapy of the coronary arteriesPhysics in Medicine & Biology, 2002
- Coronary in-stent restenosis: Current status and future strategiesJournal of the American College of Cardiology, 2002
- New Frontiers in Interventional CardiologyCirculation, 2001
- “Edge Effect” of 32 P Radioactive Stents Is Caused by the Combination of Chronic Stent Injury and Radioactive Dose FalloffCirculation, 2001
- Physiological Transport Forces Govern Drug Distribution for Stent-Based DeliveryCirculation, 2001
- Pharmacokinetics and consistency of pericardial delivery directed to coronary arteries: Direct comparison with endoluminal deliveryClinical Cardiology, 1999
- Radiation dose from a phosphorous-32 impregnated wire mesh vascular stentMedical Physics, 1997
- Tissue average binding and equilibrium distribution: an example with heparin in arterial tissuesBiophysical Journal, 1996
- Mechanisms of Transmural Heparin Transport in the Rat Abdominal Aorta After Local Vascular DeliveryCirculation Research, 1995